US 7361350
Use of an IL-1 antagonist for treating arthritis
granted A61KA61K38/00A61P
Quick answer
US patent 7361350 (Use of an IL-1 antagonist for treating arthritis) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61P, A61P29/00